Ferric Carboxymaltose is a parenteral iron solution containing ferric iron complexed with carboxymaltose polymers, used in parenteral iron-replacement therapy. Upon administration, ferric carboxymaltose is removed from plasma by the reticuloendothelial system. Subsequently, ferric iron binds to transferrin or is stored as ferritin. Transferrin-bound iron is transported in the plasma to the liver, spleen and bone marrow, where it is incorporated into hemoglobin, and to muscle, where it is incorporated into myoglobin. Its therapeutic use is listed as hematologic agents. The directory classifies it as a commercial API with a mineral/inorganic source/manufacturing origin. Other names for this substance include Injectafer and Iron Dextri-Maltose. Its PubChem CID is 481108713.
Ferric carboxymaltose
| CAS No | 9007-72-1 |
|---|---|
| Molecular Weight | ~150 kDa |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ferric Carboxymaltose is a parenteral iron solution containing ferric iron complexed with carboxymaltose polymers, used in parenteral iron-replacement therapy. Upon administration, ferric carboxymaltose is removed from plasma by the reticuloendothelial system.
The listed CAS number is 9007-72-1.
The listed molecular weight is ~150 kDa.
The source lists Injectafer and Iron Dextri-Maltose.
Its therapeutic use is listed as hematologic agents.
It is listed as a commercial API with a mineral/inorganic origin.